Buchumschlag

Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

To compare the efficacy of sodium valproate administered as adjunct to neuroleptic medication for patients with acute mania with the efficacy of neuroleptics alone, the authors conducted a 21-day, randomized, double-blind, parallel-group, placebo-controlled trial. The study design closely reflected...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Müller-Oerlinghausen, Bruno (VerfasserIn) , Retzow, Angelika (VerfasserIn) , Henn, Fritz A. (VerfasserIn) , Giedke, Henner (VerfasserIn) , Walden, Jörg (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 2000
In: Journal of clinical psychopharmacology
Year: 2000, Jahrgang: 20, Heft: 2, Pages: 195-203
ISSN:1533-712X
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/psychopharmacology/Fulltext/2000/04000/Valproate_as_an_Adjunct_to_Neuroleptic_Medication.12.aspx
Volltext
Verfasserangaben:Bruno Müller-Oerlinghausen, Angelika Retzow, Fritz A. Henn, Henner Giedke, Jörg Walden, for the European Valproate Mania Study Group

MARC

LEADER 00000caa a2200000 c 4500
001 173855631X
003 DE-627
005 20230428161423.0
007 cr uuu---uuuuu
008 201112s2000 xx |||||o 00| ||eng c
035 |a (DE-627)173855631X 
035 |a (DE-599)KXP173855631X 
035 |a (OCoLC)1341376546 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Müller-Oerlinghausen, Bruno  |d 1936-  |e VerfasserIn  |0 (DE-588)106805517  |0 (DE-627)618239723  |0 (DE-576)16408519X  |4 aut 
245 1 0 |a Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania  |b A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study  |c Bruno Müller-Oerlinghausen, Angelika Retzow, Fritz A. Henn, Henner Giedke, Jörg Walden, for the European Valproate Mania Study Group 
264 1 |c April 2000 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 12.11.2020 
520 |a To compare the efficacy of sodium valproate administered as adjunct to neuroleptic medication for patients with acute mania with the efficacy of neuroleptics alone, the authors conducted a 21-day, randomized, double-blind, parallel-group, placebo-controlled trial. The study design closely reflected a clinical psychiatric setting in Europe where patients with acute mania commonly receive neuroleptic medication. In this trial, 136 hospitalized patients met the ICD-10 criteria for acute manic episodes; these patients received a fixed dose of 20 mg/kg of body weight of sodium valproate (Orfiril, Desitin Arzneimittel GmbH, Hamburg, Germany) orally, in addition to basic neuroleptic medication, preferably haloperidol and/or perazine. The primary outcome measure was the mean dose of neuroleptic medication (after conversion into haloperidol-equivalents) for the 21-day study period. Severity of symptoms was measured using the Young Mania Rating Scale (YMRS), the Global Assessment Scale, and the Clinical Global Impression Scale. Intent-to-treat analysis was based on 69 patients treated with valproate and 67 patients who received placebo. Groups were comparable with regard to demographic and clinical baseline data. Premature discontinuations occurred in only 13% of the patients. The mean neuroleptic dose declined continuously in the valproate group, whereas only slight variations were observed in the placebo group; the difference was statistically significant (p = 0.0007) for study weeks 2 and 3. The combination of neuroleptic and valproate proved superior to neuroleptics in attempts to alleviate manic symptoms. The proportion of responders (a 50% improvement rate shown on the YMRS) was higher for the combination with valproate than for the group receiving only neuroleptics (70% vs. 46%; p = 0.005). Adverse events consisted of those known for valproate or neuroleptics; the only adverse event was asthenia, which occurred more frequently with the combination therapy. Valproate represents a useful adjunct medication for the treatment of acute manic symptoms. Valproate is beneficial because it allows the administration of fewer neuroleptic medications and produces improved and quicker remission of manic symptoms. 
700 1 |a Retzow, Angelika  |e VerfasserIn  |4 aut 
700 1 |a Henn, Fritz A.  |d 1941-  |e VerfasserIn  |0 (DE-588)17213384X  |0 (DE-627)697047938  |0 (DE-576)133005917  |4 aut 
700 1 |a Giedke, Henner  |d 1941-  |e VerfasserIn  |0 (DE-588)1146488572  |0 (DE-627)1007984104  |0 (DE-576)187438730  |4 aut 
700 1 |a Walden, Jörg  |e VerfasserIn  |0 (DE-588)129283665  |0 (DE-627)392389096  |0 (DE-576)297578375  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical psychopharmacology  |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1981  |g 20(2000), 2, Seite 195-203  |h Online-Ressource  |w (DE-627)33428998X  |w (DE-600)2057059-4  |w (DE-576)098000314  |x 1533-712X  |7 nnas  |a Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study 
773 1 8 |g volume:20  |g year:2000  |g number:2  |g pages:195-203  |g extent:9  |a Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study 
856 4 0 |u https://journals.lww.com/psychopharmacology/Fulltext/2000/04000/Valproate_as_an_Adjunct_to_Neuroleptic_Medication.12.aspx  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201112 
993 |a Article 
994 |a 2000 
998 |g 17213384X  |a Henn, Fritz A.  |m 17213384X:Henn, Fritz A.  |d 60000  |e 60000PH17213384X  |k 0/60000/  |p 3 
999 |a KXP-PPN173855631X  |e 380098024X 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyJournal of clinical psychopharmacology","pubHistory":["1.1981 -"],"recId":"33428998X","note":["Gesehen am 21.06.2019"],"origin":[{"dateIssuedKey":"1981","publisher":"Lippincott Williams & Wilkins ; Ovid","publisherPlace":"Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1981-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2057059-4"],"issn":["1533-712X"],"eki":["33428998X"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of clinical psychopharmacology","title_sort":"Journal of clinical psychopharmacology"}],"part":{"issue":"2","extent":"9","year":"2000","text":"20(2000), 2, Seite 195-203","pages":"195-203","volume":"20"}}],"person":[{"given":"Bruno","display":"Müller-Oerlinghausen, Bruno","family":"Müller-Oerlinghausen","role":"aut"},{"role":"aut","family":"Retzow","display":"Retzow, Angelika","given":"Angelika"},{"role":"aut","given":"Fritz A.","display":"Henn, Fritz A.","family":"Henn"},{"role":"aut","family":"Giedke","display":"Giedke, Henner","given":"Henner"},{"role":"aut","given":"Jörg","family":"Walden","display":"Walden, Jörg"}],"physDesc":[{"extent":"9 S."}],"title":[{"title_sort":"Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania","subtitle":"A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study","title":"Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania"}],"origin":[{"dateIssuedDisp":"April 2000","dateIssuedKey":"2000"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["173855631X"]},"language":["eng"],"note":["Gesehen am 12.11.2020"],"recId":"173855631X","name":{"displayForm":["Bruno Müller-Oerlinghausen, Angelika Retzow, Fritz A. Henn, Henner Giedke, Jörg Walden, for the European Valproate Mania Study Group"]}} 
SRT |a MUELLEROERVALPROATEA2000 

Ähnliche Einträge